Imagene

AI-based Molecular Profiling for Cancer

[Imagene @Imagene_ai]

💥 New Paper Alert: Our multi-center retrospective study on AI-driven identification of actionable NSCLC biomarkers is now published in #npjPrecisionOncology @Nature_NPJ @ChristianRolfo https://t.co/fgmALmfeq5

[Imagene @Imagene_ai]

We’re proud to share that Imagene has been named the winner of the Innovation Award in Precision Oncology at the 2025 Pharmaceutical Technology Excellence Awards. https://t.co/WOXudJxF3V

[Tempus @TempusAI]

We're excited to announce a collaboration with @Imagene_ai to advance #AI-driven diagnostics for non-small cell lung cancer. Learn more: https://t.co/poWnTleNCj #NSCLC

[Imagene @Imagene_ai]

We are pleased to announce our collaboration with Tempus to advance AI-powered diagnostics for non-small cell lung cancer (NSCLC). https://t.co/H48isVuVQH
@TempusAI

[Imagene @Imagene_ai]

Imagene, @Oracle and @EITLosAngeles unveil CanvOI: a state-of-the-art vision #foundationmodel, providing diagnostics developers and researchers an innovative tool in the fight against #cancer
https://t.co/oET2qYuBhB
@DavidAgus @larryellison #OCI #OncologyIntelligence

[The James at Ohio State @OSUCCC_James]

We're thrilled to announce that Christian Rolfo, MD, PhD, will join The James team as director of our Division of Medical #Oncology. Welcome to #BuckeyeNation Dr. Rolfo! https://t.co/ox9IDeMP8U

[Imagene @Imagene_ai]

Congratulations to @ChristianRolfo on his appointment as Director of the Division of Medical Oncology at OSUCCC. Proud to have such an accomplished leader on @Imagene_ai scientific advisory board. Your contributions to oncology continue to inspire us all!
https://t.co/JUEgFLKBxe

[Imagene @Imagene_ai]

We're excited to share the culmination of key milestones of our flag ship product LungOI - CLIA certification, LDT product launch, and Medicare code and rate.
https://t.co/OK6uR30lJm

[Imagene @Imagene_ai]

@TIME named @larryellison one of the 100 Most Influential People of 2024 #TIME100. We are fortunate to have such a visionary leader as a key investor, supporter, and believer in @Imagene_ai
https://t.co/A7gJOBbi8P

[Imagene @Imagene_ai]

Some of our esteemed advisors have established a new reporting standards for NGS results in NSCLC. Congrats to @ChristianRolfo @NatashaLeighl, @Nirpeled @DovHershkovitz @MaximilianHochmair, and their collaborators on this significant achievement!
https://t.co/D1zdVTuHfg

[Imagene @Imagene_ai]

#ASCO2024 is less than a month away.
We will be showcasing the latest advancements in AI-based biomarker profiling solutions, stop by and meet us at Booth #10064.
Schedule a meeting in advance: https://t.co/NtdE72Do4D

[Imagene @Imagene_ai]

Happy to announce the availability of ImageneOI, the first NSCLC genomic profiling AI tool on the Sectra Marketplace. Healthcare providers can seamlessly access and use rapid AI-based NSCLC biomarker profiling https://t.co/vNdOeU612R

#digitalpathology @SectraNews

[Imagene @Imagene_ai]

Honor to be selected as one of the Top 20 Promising Precision Medicine Startups. @StartUsInsights conducted an in-depth research on the Top 10 Trends in Precision Medicine and analyzed ~1700 global startups & scaleups with technologies that revolutionizes pharma and healthcare.

[StartUs Insights @StartUsInsights]

💊 Discover top 10 #PrecisionMedicine trends in 2024 & get insights into solutions like molecular #diagnostics, #radiomics, precision #oncology & more 👉 https://t.co/H4EPFkcY0T

@onecelldx @genomadix @Imagene_ai @Ocean_Genomics @MantaraHealth @eisbachbio #pharma

[Imagene @Imagene_ai]

Happy to start 2024 at #JPM2024 where innovation meet healthcare leadership. @DeanBitan our Co-founder & CEO would be happy to meet and discuss how Immediate Oncology Intelligence can transform cancer diagnosis and care. DM or schedule a meeting https://t.co/Ay01hWWyPm

[Imagene @Imagene_ai]

November is #LungCancerAwarenessMonth
Awareness and education play pivotal roles in saving lives. Just as crucially is understanding the unique drivers behind each patient's cancer and tailoring therapy to the individual makeup of their tumor
#moleculartesting #precisiononcology

[Imagene @Imagene_ai]

Our newly paper in @Cancers_MDP showcase an AI-based methodology that can detect double/triple-hit events using only the diagnostic WSI. Showing the potential of rapid AI analysis in supporting the diagnosis process in hematopathology. https://t.co/wS66sugE7m

[Imagene @Imagene_ai]

We’re live at #PathologyVisions23 in Orlando, come to visit us at booth #406 and join us for an enlightening session on "Immediate Image-Based Molecular Profiling" with Addie Dvir, MSc, Head of Diagnostics - October 31st at 12:55pm
#DigitalPathology #MolecularPathology

[Imagene @Imagene_ai]

3/3 Thank you Stephen Klasko for receiving the award on our behalf. Imagene AI will continue to drive innovation, creativity and improve cancer diagnosis and care for patients.
https://t.co/vHePq0DdGq
#digitalhealthawards2023 #HealthAI #recognition #standwithisrael

[Imagene @Imagene_ai]

1/3 In these difficult times, we received a message that made us proud. We were just notified that we have been selected as the 2023 winners in the Digital Health Awards for Best use of AI in Health Tech.

Unfortunately, we were not there. We would like to dedicate this award

[Imagene @Imagene_ai]

2/3 to all the innocent people that were murdered in Israel in the past few days by brutal unhunan terrorists, and also to all the brave civilians and soldiers who risked and still risking their lives in amazing bravery stories to save lives.